Buys
166 IDRA 14.99 NH Up from 12 in mid
June.
Support at 12 and 13. 21-day, Accum. Index bulge in
April - Expect breakput run to 20+.
http://www.iderapharma.com
Idera Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and
development of DNA- and RNA-based compounds for the treatment of infectious diseases,
autoimmune diseases,
cancer, and asthma and allergies and for use as vaccine adjuvants. 38 employees
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA
- News), a biopharmaceutical company
focused on developing therapeutics targeting Toll-Like Receptors (TLR), today announced
that it will discuss its TLR-targeted drug discovery and development programs and provide
a general corporate overview at the following conferences:
- BMO Capital Markets Focus on Healthcare Conference, on
Wednesday, August 6, 2008 at 10:45 a.m. (EDT) at the Millennium Broadway Hotel in New York
City.
- Canaccord Adams 28th Annual
Global Growth Conference, on Thursday, August 14, 2008 at 11:00 a.m. (EDT) at the
Intercontinental Hotel in Boston.
The presentations will be available via live audio webcast on the Companys website at www.iderapharma.com.


142 HNV 32.89 IP21=.65 OBV is confirming. 34=12 mo
high.
I can't find on Yahoo any information.

ILMN 165 92.74 -.50 OBV confirming. IP21=.20 ITRS=.30
High volume on last new high.
llumina Inc.
9885 Towne Centre Drive
San Diego, CA 92121
United States - Map
Phone: 858-202-4500
Fax: 858-587-4297
Web Site: http://www.illumina.com
Illumina, Inc. engages in the development, manufacture, and marketing of integrated
systems for the analysis of
genetic variation and biological function. It provides a line of products and services
that serve the sequencing,
genotyping, and gene expression markets. This is
a very good way to play biotech and genetic research.
Illumina to Present at the Leerink Swann Life Science
Tools Roundtable Conference
Thursday July 31, 6:00 am ET SAN
DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN - News)
announced today that the Company will webcast its presentation at the Leerink Swann Life
Science Tools Roundtable
Conference on Thursday, August 7, 2008 in New York, NY. The live webcast is scheduled to
begin at 10:40am ET
and will feature a discussion with Jay Flatley, President and Chief Executive Officer,
about the Company's commercial
and product development activity.

MYGN 66.20 -.30 Buy B12 IP21=.45 Myriad Genetics
Myriad Genetics Inc.
320 Wakara Way
Salt Lake City, UT 84108
United States - Map
Phone: 801-584-3600
Fax: 801-584-3640
Web Site: http://www.myriad.com
Message board shows a number of shorts want to scare the stock down.
Myriad Genetics (Nasdaq: MYGN) has a test to determine whether
patients will have an adverse reaction
to the chemotherapy treatment 5-FU/capecitabine.


NUVA 55.23 -.94 OBV confirms...IP21=.25 AI/200=119
NuVasive, Inc., a medical device company, engages in the design, development, and
marketing of products
for the surgical treatment of spine disorders. Its products are used in applications for
spine fusion surgery.
NuVasive, Inc.
4545 Towne Centre Court
San Diego, CA 92121
United States - Map
Phone: 858-909-1800
Fax: 858-909-2085
Web Site: http://www.nuvasive.com


155 IDIX 8.56 +.27
Idenix Pharmaceuticals Inc.
60 Hampshire Street
Cambridge, MA 02139
United States - Map
Phone: 617-995-9800 219 employees
Web Site: http://www.idenix.com
denix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and
development
of drugs for the treatment of human viral and other infectious diseases in the United
States and Europe.
Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals
Conference
Thursday July 31, 4:30 pm ET . CAMBRIDGE, Mass., July 31
/PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc.
(Nasdaq: IDIX - News) announced today that Idenix
management will present a corporate overview at the Bank of America
2008 Specialty Pharmaceuticals Conference on Friday, August 8, 2008 at 11:00am ET at the
Southampton Inn,
Long Island, NY.
Message board is full of nervous bashers.


CRY - 13.66 +.07 AI/200=161 19-20 is target.
CryoLife Inc.
1655 Roberts Boulevard NW
Kennesaw, GA 30144
United States - Map
Phone: 770-419-3355
Fax: 770-952-9743
Web Site: http://www.cryolife.com 405
employees
CryoLife, Inc. develops and commercializes biomaterials and implantable medical devices in
the United States and internationally. The company's product includes BioGlue, a polymer
based on bovine blood protein and an agent for cross-linking proteins designed for
cardiac, vascular, pulmonary, and general surgical applications, as well as used as an
adjunct to sutures and staples for use in adult patients in open surgical repair of large
vessels. It markets BioGlue to physicians and distributes it through its technical
representatives, as well as provides soft tissue repairs.
CryoLife
Inc. followed a first quarter of bottom-line growth with a 200 percent jump in profit
in the second
quarter of 2008.
The Kennesaw, Ga.-based biomaterials, medical device and tissue processing company
(NYSE: CRY) had net income of $3.9 million and earnings of 14 cents a share, compared with
net income of $1.3 million and earnings of 5 cents a share in the second quarter of 2007.
Net income in the second quarter of 2008 included a gain of $610,000 for the adjustment of
reserves for product liability losses, while the second quarter of 2007 had a similar
$490,000 gain.
Second-quarter revenue rose 18.3 percent to $27.2 million. Tissue processing revenue
climbed 17 percent to $13.7 million, combined cardiac and vascular tissue processing
revenue jumped 28 percent to $13.4 million and BioGlue Surgical Adhesive revenue rose 19
percent to $13 million. Orthopaedic tissue processing revenue fell 76 percent to $297,000.
Research and development costs were $1.3 million and $1 million in the second quarters
of 2008 and 2007, respectively.

|
Short Sales
These
are stocks making new lows, ranked "bearish" by TigerSoft and
show
a current Accumulation Index value below the 21-day ma of the AI.
60 CBS 15.98 -.38


35
SPAR 5.11 -.31
Spartan Motors Inc.
1165 Reynolds Road
Charlotte, MI 48813
United States - Map
Phone: 517-543-6400
Fax: 517-543-7727
Web Site: http://www.spartanmotors.com

64 WNR
7.58 -.38 2 Western Refining.
6500 Trowbridge Drive
El Paso, TX 79905
United States - Map
Phone: 915-775-3300
Web Site: http://www.westernrefining.com
Western Refining, Inc., through its subsidiaries, operates as an independent crude oil
refiner and marketer
of refined products.


28 WFMI 21.42 -.75
Whole Foods
550 Bowie Street
Austin, TX 78703-4677
United States - Map
Phone: 512-477-4455
Fax: 512-482-7000
Web Site: http://www.wholefoods.com
Whole Foods Market, Inc. and its subsidiaries engage in the ownership and operation of
natural and organic foods supermarkets. It offers produce, seafood, grocery, meat and
poultry, bakery, prepared foods and catering, specialty (beer, wine, and cheese), whole
body (nutritional supplements, vitamins, body care, and educational products), floral, pet
products, and household products. As of May 13, 2008, the company operated 269 stores


|